Target intelligence / Profile preview

DNA primase small subunit (PRIM1) (PRIM1)

Target
PRIM1
Molecular classification
Enzyme
01

Overview

The DNA primase small subunit (PRIM1, also known as p49) is the catalytic component of the eukaryotic DNA primase heterodimer, which functions within the DNA polymerase alpha-primase complex to initiate DNA replication. It synthesizes short RNA primers (typically 9-mers) de novo on single-stranded DNA templates at replication forks, enabling the leading and lagging strand synthesis by providing starting points for DNA polymerases delta and epsilon after initial extension by polymerase alpha. PRIM1 requires a template thymine or cytidine to start priming with an adenine or guanine at the primer's 5'-end, and it incorporates only ribonucleotides despite the presence of deoxyribonucleotides. The subunit partners with the regulatory large subunit (PRIM2 or p58) for stability and activity, undergoing conformational changes via a flexible linker in p58 to switch between initiation and elongation phases. Crystal structures reveal its organization, including an iron-sulfur cluster in the associated complex aiding nucleotide binding. PRIM1 is essential for S-phase progression, recruited via interactions with MCM10 and WDHD1. Biallelic mutations cause rare disorders like primordial dwarfism-immunodeficiency-lipodystrophy syndrome, highlighting its role in growth and immunity. As a drug target, its inhibition disrupts replication but poses challenges due to broad toxicity.

Other names
PRIM1primase DNA polypeptide 1 (49kDa)p49PRI1
02

Biological functions

DNA replicationsynthesis of RNA primers for Okazaki fragmentsinitiation of DNA synthesis
03

Disease associations

Primordial dwarfism-immunodeficiency-lipodystrophy syndromeSeckel syndrome
04

Safety considerations

Essential for DNA replication; inhibition likely causes severe cytotoxicity due to cell cycle disruption.

Beyond the preview

Go deeper on DNA primase small subunit (PRIM1) (PRIM1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA primase small subunit (PRIM1) (PRIM1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call